Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$229.03 - $291.01 $2.59 Million - $3.29 Million
-11,297 Reduced 70.19%
4,798 $0
Q3 2022

Oct 31, 2022

SELL
$224.46 - $253.15 $967,871 - $1.09 Million
-4,312 Reduced 21.13%
16,095 $3.63 Million
Q2 2022

Jul 25, 2022

SELL
$230.71 - $256.74 $330,607 - $367,908
-1,433 Reduced 6.56%
20,407 $4.97 Million
Q1 2022

May 03, 2022

SELL
$219.27 - $242.57 $927,512 - $1.03 Million
-4,230 Reduced 16.23%
21,840 $5.28 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $1.13 Million - $1.3 Million
-5,696 Reduced 17.93%
26,070 $5.87 Million
Q3 2021

Oct 25, 2021

BUY
$212.27 - $248.7 $1.92 Million - $2.25 Million
9,064 Added 39.93%
31,766 $6.76 Million
Q2 2021

Jul 30, 2021

BUY
$233.58 - $259.14 $334,720 - $371,347
1,433 Added 6.74%
22,702 $5.53 Million
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $1.97 Million - $2.3 Million
8,894 Added 71.87%
21,269 $5.29 Million
Q4 2020

Feb 04, 2021

BUY
$216.38 - $257.67 $117,277 - $139,657
542 Added 4.58%
12,375 $2.85 Million
Q3 2020

Oct 27, 2020

SELL
$234.65 - $260.95 $2.59 Million - $2.88 Million
-11,026 Reduced 48.23%
11,833 $3.01 Million
Q2 2020

Jul 29, 2020

SELL
$197.81 - $242.74 $3.81 Million - $4.68 Million
-19,273 Reduced 45.74%
22,859 $5.39 Million
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $388,900 - $515,787
-2,134 Reduced 4.82%
42,132 $8.54 Million
Q4 2019

Feb 03, 2020

SELL
$189.21 - $243.2 $104,065 - $133,760
-550 Reduced 1.23%
44,266 $10.7 Million
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $392,269 - $470,020
2,253 Added 5.29%
44,816 $8.67 Million
Q2 2019

Jul 31, 2019

BUY
$166.7 - $195.41 $3.01 Million - $3.53 Million
18,054 Added 73.66%
42,563 $7.84 Million
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $730,714 - $823,675
-4,040 Reduced 14.15%
24,509 $4.66 Million
Q4 2018

Jan 29, 2019

SELL
$178.4 - $208.25 $383,738 - $447,945
-2,151 Reduced 7.01%
28,549 $5.56 Million
Q3 2018

Oct 31, 2018

SELL
$185.29 - $208.89 $526,223 - $593,247
-2,840 Reduced 8.47%
30,700 $6.36 Million
Q2 2018

Jul 27, 2018

SELL
$166.05 - $186.51 $200,920 - $225,677
-1,210 Reduced 3.48%
33,540 $6.19 Million
Q1 2018

Apr 25, 2018

SELL
$169.43 - $198.0 $2.99 Million - $3.49 Million
-17,622 Reduced 33.65%
34,750 $5.92 Million
Q4 2017

Jan 30, 2018

BUY
$168.79 - $188.59 $8,439 - $9,429
50 Added 0.1%
52,372 $9.11 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $8.75 Million - $9.99 Million
52,322
52,322 $9.76 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Capital Management Corp Portfolio

Follow Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Capital Management Corp with notifications on news.